Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers-Reference-Cited by-同舟云学术

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

Published:2012-02 Issue:1 Volume:14 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Antoniou Antonis C, ,Kuchenbaecker Karoline B,Soucy Penny,Beesley Jonathan,Chen Xiaoqing,McGuffog Lesley,Lee Andrew,Barrowdale Daniel,Healey Sue,Sinilnikova Olga M,Caligo Maria A,Loman Niklas,Harbst Katja,Lindblom Annika,Arver Brita,Rosenquist Richard,Karlsson Per,Nathanson Kate,Domchek Susan,Rebbeck Tim,Jakubowska Anna,Lubinski Jan,Jaworska Katarzyna,Durda Katarzyna,Złowowcka-Perłowska Elżbieta,Osorio Ana,Durán Mercedes,Andrés Raquel,Benítez Javier,Hamann Ute,Hogervorst Frans B,van Os Theo A,Verhoef Senno,Meijers-Heijboer Hanne EJ,Wijnen Juul,Gómez Garcia Encarna B,Ligtenberg Marjolijn J,Kriege Mieke,Collée J Margriet,Ausems Margreet GEM,Oosterwijk Jan C,Peock Susan,Frost Debra,Ellis Steve D,Platte Radka,Fineberg Elena,Evans D Gareth,Lalloo Fiona,Jacobs Chris,Eeles Ros,Adlard Julian,Davidson Rosemarie,Cole Trevor,Cook Jackie,Paterson Joan,Douglas Fiona,Brewer Carole,Hodgson Shirley,Morrison Patrick J,Walker Lisa,Rogers Mark T,Donaldson Alan,Dorkins Huw,Godwin Andrew K,Bove Betsy,Stoppa-Lyonnet Dominique,Houdayer Claude,Buecher Bruno,de Pauw Antoine,Mazoyer Sylvie,Calender Alain,Léoné Mélanie,Bressac- de Paillerets Brigitte,Caron Olivier,Sobol Hagay,Frenay Marc,Prieur Fabienne,Ferrer Sandra Fert,Mortemousque Isabelle,Buys Saundra,Daly Mary,Miron Alexander,Terry Mary Beth,Hopper John L,John Esther M,Southey Melissa,Goldgar David,Singer Christian F,Fink-Retter Anneliese,Tea Muy-Kheng,Kaulich Daphne Geschwantler,Hansen Thomas VO,Nielsen Finn C,Barkardottir Rosa B,Gaudet Mia,Kirchhoff Tomas,Joseph Vijai,Dutra-Clarke Ana,Offit Kenneth,Piedmonte Marion,Kirk Judy,Cohn David,Hurteau Jean,Byron John,Fiorica James,Toland Amanda E,Montagna Marco,Oliani Cristina,Imyanitov Evgeny,Isaacs Claudine,Tihomirova Laima,Blanco Ignacio,Lazaro Conxi,Teulé Alex,Valle J Del,Gayther Simon A,Odunsi Kunle,Gross Jenny,Karlan Beth Y,Olah Edith,Teo Soo-Hwang,Ganz Patricia A,Beattie Mary S,Dorfling Cecelia M,van Rensburg Elizabeth Jansen,Diez Orland,Kwong Ava,Schmutzler Rita K,Wappenschmidt Barbara,Engel Christoph,Meindl Alfons,Ditsch Nina,Arnold Norbert,Heidemann Simone,Niederacher Dieter,Preisler-Adams Sabine,Gadzicki Dorothea,Varon-Mateeva Raymonda,Deissler Helmut,Gehrig Andrea,Sutter Christian,Kast Karin,Fiebig Britta,Schäfer Dieter,Caldes Trinidad,de la Hoya Miguel,Nevanlinna Heli,Muranen Taru A,Lespérance Bernard,Spurdle Amanda B,Neuhausen Susan L,Ding Yuan C,Wang Xianshu,Fredericksen Zachary,Pankratz Vernon S,Lindor Noralane M,Peterlongo Paolo,Manoukian Siranoush,Peissel Bernard,Zaffaroni Daniela,Bonanni Bernardo,Bernard Loris,Dolcetti Riccardo,Papi Laura,Ottini Laura,Radice Paolo,Greene Mark H,Loud Jennifer T,Andrulis Irene L,Ozcelik Hilmi,Mulligan Anna Marie,Glendon Gord,Thomassen Mads,Gerdes Anne-Marie,Jensen Uffe B,Skytte Anne-Bine,Kruse Torben A,Chenevix-Trench Georgia,Couch Fergus J,Simard Jacques,Easton Douglas F, , , ,

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3121.pdf

Reference39 articles.

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-1130. 10.1086/375033.

2. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL: Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008, 299: 194-201. 10.1001/jama.2007.55-a.

3. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kampjarvi K, Nevanlinna H, Simard J, Beesley J, Chen X, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, et al: Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008, 82: 937-948. 10.1016/j.ajhg.2008.02.008.

4. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, et al: Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2009, 18: 4442-4456. 10.1093/hmg/ddp372.

5. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, et al: Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010, 70: 9742-9754. 10.1158/0008-5472.CAN-10-1907.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond;Cancers;2024-01-30

2. The Long Non-Coding RNA ANRIL in Cancers;Cancers;2023-08-17

3. Olaparib efficacy in patients with germline BRCA‐mutated, HER2‐negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial;International Journal of Cancer;2023-04-06

4. Endocrine therapy in metastatic breast cancer-more than just CDK4/6 inhibitors;Journal of Cancer Metastasis and Treatment;2023

5. Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper;Journal of Geriatric Oncology;2022-06